Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,940 | 260 | 67.0% |
| Consulting Fee | $2,400 | 1 | 32.5% |
| Education | $35.91 | 5 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $2,879 | 30 | $0 (2018) |
| AbbVie Inc. | $770.16 | 37 | $0 (2020) |
| GENZYME CORPORATION | $620.29 | 21 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $493.04 | 32 | $0 (2020) |
| Amgen Inc. | $339.89 | 19 | $0 (2018) |
| GlaxoSmithKline, LLC. | $269.65 | 11 | $0 (2020) |
| Celgene Corporation | $260.64 | 21 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $254.57 | 14 | $0 (2018) |
| Lilly USA, LLC | $250.95 | 15 | $0 (2018) |
| PFIZER INC. | $249.38 | 16 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $197.93 | 2 | GENZYME CORPORATION ($197.93) |
| 2021 | $73.98 | 1 | GENZYME CORPORATION ($73.98) |
| 2020 | $149.25 | 3 | AbbVie Inc. ($86.24) |
| 2019 | $440.17 | 7 | GlaxoSmithKline, LLC. ($145.87) |
| 2018 | $4,168 | 115 | UCB, Inc. ($2,653) |
| 2017 | $2,347 | 138 | AbbVie, Inc. ($378.91) |
All Payment Transactions
266 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/03/2022 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $118.46 | General |
| 05/12/2022 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $79.47 | General |
| 06/11/2021 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $73.98 | General |
| 12/23/2020 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: IMMUNOLOGY | ||||||
| 02/25/2020 | AbbVie Inc. | RINVOQ (Drug) | Food and Beverage | In-kind items and services | $86.24 | General |
| Category: IMMUNOLOGY | ||||||
| 02/05/2020 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $50.28 | General |
| Category: IMMUNOLOGY | ||||||
| 09/11/2019 | AbbVie Inc. | Rinvoq (Biological) | Education | In-kind items and services | $14.80 | General |
| Category: Immunology | ||||||
| 09/09/2019 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $8.66 | General |
| Category: IMMUNOLOGY | ||||||
| 08/29/2019 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $123.73 | General |
| Category: IMMUNOLOGY | ||||||
| 05/04/2019 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $54.49 | General |
| 05/03/2019 | GENZYME CORPORATION | RHEUMATOID ARTHRITIS DISEASE (Drug) | Food and Beverage | In-kind items and services | $93.42 | General |
| 05/02/2019 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $131.59 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 02/11/2019 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: IMMUNOLOGY | ||||||
| 11/28/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $6.09 | General |
| Category: Immunology | ||||||
| 10/17/2018 | UCB, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,400.00 | General |
| 09/10/2018 | E.R. Squibb & Sons, L.L.C. | — | Education | Cash or cash equivalent | $3.75 | General |
| 09/08/2018 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 09/08/2018 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $25.00 | General |
| 08/31/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Immunology | ||||||
| 08/29/2018 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $15.07 | General |
| Category: Immunology | ||||||
| 08/27/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: Immunology | ||||||
| 08/24/2018 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Immunology | ||||||
| 08/23/2018 | Genentech USA, Inc. | Rituxan (Biological), Actemra | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: BioOncology/Immunology | ||||||
| 08/22/2018 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $24.27 | General |
| 08/22/2018 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 2 | 46 | 47 | $13,200 | $1,441 |
| 2020 | 7 | 268 | 407 | $124,488 | $22,328 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 34 | 35 | $8,820 | $934.29 | 10.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 12 | 12 | $4,380 | $506.51 | 11.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 73 | 129 | $46,149 | $9,594 | 20.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 93 | 140 | $34,272 | $6,918 | 20.2% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 22 | 22 | $14,885 | $3,311 | 22.2% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2020 | 25 | 43 | $22,017 | $1,810 | 8.2% |
| 20605 | Aspiration and/or injection of medium joint or joint capsule | Office | 2020 | 13 | 14 | $5,520 | $497.01 | 9.0% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2020 | 24 | 37 | $1,105 | $144.41 | 13.1% |
| J1020 | Injection, methylprednisolone acetate, 20 mg | Office | 2020 | 18 | 22 | $540.00 | $53.98 | 10.0% |
About Dr. Gary Botstein, M.D
Dr. Gary Botstein, M.D is a Rheumatology healthcare provider based in Decatur, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003853177.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Botstein, M.D has received a total of $7,376 in payments from pharmaceutical and medical device companies, with $197.93 received in 2022. These payments were reported across 266 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($4,940).
As a Medicare-enrolled provider, Botstein has provided services to 314 Medicare beneficiaries, totaling 454 services with total Medicare billing of $23,769. Data is available for 2 years (2020–2021), covering 9 distinct procedure/service records.
Practice Information
- Specialty Rheumatology
- Location Decatur, GA
- Active Since 05/31/2006
- Last Updated 02/28/2011
- Taxonomy Code 207RR0500X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1003853177
Products in Payments
- Humira (Biological) $577.34
- COSENTYX (Biological) $493.04
- Cimzia (Drug) $404.18
- KEVZARA (Drug) $345.01
- BENLYSTA (Biological) $269.65
- Enbrel (Biological) $261.45
- XELJANZ (Drug) $246.65
- FORTEO (Drug) $211.59
- ORENCIA (Biological) $201.14
- ACTHAR (Biological) $170.30
- Rituxan (Biological) $149.40
- SOLIRIS (Drug) $104.44
- XARELTO (Drug) $95.81
- RHEUMATOID ARTHRITIS DISEASE (Drug) $93.42
- RINVOQ (Drug) $86.24
- Prolia (Biological) $58.40
- REMICADE (Biological) $53.00
- TALTZ (Drug) $39.36
- RAYOS (Drug) $37.35
- OPSUMIT MACITENTAN (Drug) $34.51
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Decatur
Jefrey Lieberman, Md, MD
Rheumatology — Payments: $353,561
Amir Agha, Md, MD
Rheumatology — Payments: $90,918
Arshad Mustafa, M.d, M.D
Rheumatology — Payments: $13,092
Nehemiah Tan, M.d, M.D
Rheumatology — Payments: $6,024
Emily Peninger, Md, MD
Rheumatology — Payments: $3,320
Manoj Kohli, Md, MD
Rheumatology — Payments: $1,351